Scribd Logo
Upload

Welcome to Scribd!

  • 35 views

    October 2002

    Uploaded by

    Joseph Ochoa
    The document provides guidelines for pharmacists on when to provide Consumer Medicine Information to consumers. Pharmacists must use their professional judgement to decide when to provide CMI and are not required to do so with every prescription dispensed. CMI should generally be provided when medicine is first provided, if there are significant changes to the CMI, changes to dosage form, for medicines used long term every six months, when requested by the patient, and when there are reasons for regular reinforcement of information such as if the medication is teratogenic. Pharmacists participating in the Medicines Information to Consumers Program must also promote the availability of CMI in their pharmacy.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd

    October 2002

    Uploaded by

    Joseph Ochoa
    35 views1 page
    The document provides guidelines for pharmacists on when to provide Consumer Medicine Information to consumers. Pharmacists must use their professional judgement to decide when to provide CMI and are not required to do so with every prescription dispensed. CMI should generally be provided when medicine is first provided, if there are significant changes to the CMI, changes to dosage form, for medicines used long term every six months, when requested by the patient, and when there are reasons for regular reinforcement of information such as if the medication is teratogenic. Pharmacists participating in the Medicines Information to Consumers Program must also promote the availability of CMI in their pharmacy.

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The document provides guidelines for pharmacists on when to provide Consumer Medicine Information to consumers. Pharmacists must use their professional judgement to decide when to provide CMI and are not required to do so with every prescription dispensed. CMI should generally be provided when medicine is first provided, if there are significant changes to the CMI, changes to dosage form, for medicines used long term every six months, when requested by the patient, and when there are reasons for regular reinforcement of information such as if the medication is teratogenic. Pharmacists participating in the Medicines Information to Consumers Program must also promote the availability of CMI in their pharmacy.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    35 views1 page

    October 2002

    Uploaded by

    Joseph Ochoa
    The document provides guidelines for pharmacists on when to provide Consumer Medicine Information to consumers. Pharmacists must use their professional judgement to decide when to provide CMI and are not required to do so with every prescription dispensed. CMI should generally be provided when medicine is first provided, if there are significant changes to the CMI, changes to dosage form, for medicines used long term every six months, when requested by the patient, and when there are reasons for regular reinforcement of information such as if the medication is teratogenic. Pharmacists participating in the Medicines Information to Consumers Program must also promote the availability of CMI in their pharmacy.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    OCTOBER 2002

    WHEN TO PROVIDE CONSUMER


    MEDICINE INFORMATION....
    Pharmacists participating in the Medicines Information to Consumers (MIC) Program are
    required to provide Consumer Medicine Information (CMI) to consumers in accordance with
    PSA professional standards and guidelines.*

    CMI does not need to be provided with every prescription dispensed. In the final analysis,
    pharmacists themselves—exercising their professional judgement—will make the decision
    whether or not to provide CMI.

    According to the PSA guidelines, all counselling on dispensed medicines must be conducted
    by a pharmacist.

    CMI should generally be provided:

    1. When a medicine is first provided to a consumer.

    2. On provision of medicine where:


    — a significant change to the CMI has been notified by a sponsor; or
    — the dosage form has been changed.

    3. With each supply of medicine for which there are valid reasons for regular reinforcement
    of information. For example, when:
    — the medication is teratogenic;
    — there are major contraindications to the use of a medicine; or
    — the patient has special needs.

    4. When the patient requests the information.

    5. At regular intervals for medicines used for long term therapy – for example, every six months.

    NOTE: As an approved participant in the MIC Program, you also need to promote to consumers
    the availability of CMI in your pharmacy.

    Patient Counselling. PSA Professional Practice Standards, Version 2 (2002), pp. 22-25.
    * Consumer Medicines Information and the Pharmacist. PSA Pharmacy Practice Handbook (2000), pp. 37-38.
    Guidelines for Pharmacists on Providing Medicines Information to Patients. PSA Pharmacy Practice Handbook (2000), pp. 39-42.

    You might also like

    pFad - Phonifier reborn

    Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

    Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


    Alternative Proxies:

    Alternative Proxy

    pFad Proxy

    pFad v3 Proxy

    pFad v4 Proxy